NR1H3 and atherosclerosis: However, the autoregulation of ligand-activated LXRα in human foam cells varies significantly from mouse foam cells [10], showing one of the severe limitations of using mouse models for studying the physiological effects of drug candidates for treating atherosclerosis [2].